Related references
Note: Only part of the references are listed.Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
Burak Mergen et al.
EYE (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice Data from the Fight Retinal Blindness! Registry
Pierre-Henry Gabrielle et al.
OPHTHALMOLOGY RETINA (2020)
Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use
Qi N. Cui et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure An Analysis Using the IRIS Registry
Elizabeth A. Atchison et al.
OPHTHALMOLOGY (2018)
The outcomes of aflibercept therapy in patients with age-related macular degeneration resistant to bevacizumab or ranibizumab
Erkan Unsal et al.
JOURNAL OF CURRENT OPHTHALMOLOGY (2018)
Association between open-angle glaucoma and neovascular age-related macular degeneration: a case-control study
C-C Hu et al.
EYE (2017)
Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Brennan D. Eadie et al.
JAMA OPHTHALMOLOGY (2017)
Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Alexander J. E. Foss et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Yandan Zhou et al.
SCIENTIFIC REPORTS (2016)
Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
K. Bailey Freund et al.
OPHTHALMOLOGY (2015)
Burden of Undetected and Untreated Glaucoma in the United States
Yahya Shaikh et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis
Yih-Chung Tham et al.
OPHTHALMOLOGY (2014)
Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials
Sophie J. Bakri et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
INTRAOCULAR PRESSURE IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION SWITCHED TO AFLIBERCEPT INJECTION AFTER PREVIOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENTS
Irene M. Rusu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Complications of Subspecialty Ophthalmic Care: Endophthalmitis after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Medications
Luis J. Haddock et al.
SEMINARS IN OPHTHALMOLOGY (2014)
Complications of Subspecialty Ophthalmic Care: Systemic Complications from the Intravitreal Administration of Agents that Target the Vascular Endothelial Growth Factor Pathway
David J. Ramsey et al.
SEMINARS IN OPHTHALMOLOGY (2014)
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Sharon D. Solomon et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Aflibercept-Related Sterile Inflammation
Paul Hahn et al.
OPHTHALMOLOGY (2013)
CLINICAL PREDICTORS OF SUSTAINED INTRAOCULAR PRESSURE ELEVATION DUE TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Quan V. Hoang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Ocular Hypertension and Intraocular Pressure Asymmetry After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
Suzann Pershing et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2013)
Sustained Increased Intraocular Pressure Related to Intravitreal Antivascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration
Joseph J. Tseng et al.
JOURNAL OF GLAUCOMA (2012)
Reduction in Intraocular Pressure after Cataract Extraction: The Ocular Hypertension Treatment Study
Steven L. Mansberger et al.
OPHTHALMOLOGY (2012)
Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Quan V. Hoang et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization
Neil M. Bressler et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
Travis J. Good et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sustained Elevation in Intraocular Pressure Associated With Intravitreal Bevacizumab Injections
Malik Y. Kahook et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2009)
Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab
S. J. Bakri et al.
EYE (2009)
Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration
G. Mojica et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Persisent ocular hypertension following intravitreal ranibizumab
Sophie J. Bakri et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the Medicare population
Gergana P. Zlateva et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
